180 related articles for article (PubMed ID: 11266931)
1. IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection.
Jiang H; Yang XF; Wynn C; Soriano R; Krishnan K; Fujimura T; Kobayashi M
Transplant Proc; 2001; 33(1-2):510-3. PubMed ID: 11266931
[No Abstract] [Full Text] [Related]
2. Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration.
Ebbs A; Pan F; Wynn C; Erickson L; Kobayashi M; Jiang H
Transplant Proc; 2002 Aug; 34(5):1378-81. PubMed ID: 12176404
[No Abstract] [Full Text] [Related]
3. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat.
Jiang H; Yang XF; Soriano R; Fujitsu T; Kobayashi M
Transplant Proc; 1999; 31(1-2):1203-5. PubMed ID: 10083538
[No Abstract] [Full Text] [Related]
5. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation.
Li W; Lu L; Li Y; Fu F; Fung JJ; Thomson AW; Qian S
Transplant Proc; 1997; 29(1-2):1081-2. PubMed ID: 9123209
[No Abstract] [Full Text] [Related]
6. Donor-specific antigen transfusion-mediated cardiac allograft tolerance is prevented by prior treatment with anti-CD8, but not anti-CD4, antibody.
Shimizu Y; Otomo N; Yu S; Margenthaler JA; Flye MW
Transplant Proc; 2001; 33(1-2):150-1. PubMed ID: 11266753
[No Abstract] [Full Text] [Related]
7. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467
[No Abstract] [Full Text] [Related]
8. Putative regulatory function of alloreactive Th2 cells in tolerant recipients after small bowel transplantation.
Gasser M; Otto C; Timmermann W; Waaga AM; Meyer D; Gassel HJ; Ulrichs K; Thiede A
Transplant Proc; 2001; 33(1-2):161-2. PubMed ID: 11266759
[No Abstract] [Full Text] [Related]
9. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
[No Abstract] [Full Text] [Related]
10. Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB.
Zhang Z; Zhong R; Jiang J; Wang J; Garcia B; Le Feuvre C; White M; Stiller C; Lazarovits A
Transplant Proc; 1997; 29(1-2):1253. PubMed ID: 9123294
[No Abstract] [Full Text] [Related]
11. Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival.
Jiang H; Sakuma S; Fujii Y; Akiyama Y; Ogawa T; Tamura K; Kobayashi M; Fujitsu T
Transpl Int; 1999; 12(2):92-9. PubMed ID: 10363590
[TBL] [Abstract][Full Text] [Related]
12. Cellular basis of long-term rat liver allograft acceptance: role of donor and recipient leukocyte persistence in rat liver grafts.
Steger U; Klein I; Otto C; Meyer D; Timmermann W; Ulrichs K; Thiede A; Gassel HJ
Transplant Proc; 2001; 33(1-2):185-6. PubMed ID: 11266772
[No Abstract] [Full Text] [Related]
13. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945
[No Abstract] [Full Text] [Related]
14. Effect of selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 MAb in rat small bowel transplantation.
Gasser M; Timmermann W; Vowinkel T; Tykal K; Hoppe H; Otto C; Gassel AM; Meyer D; Ulrichs K; Thiede A
Transplant Proc; 1998 Sep; 30(6):2605-6. PubMed ID: 9745510
[No Abstract] [Full Text] [Related]
15. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
[TBL] [Abstract][Full Text] [Related]
16. Features of tolerance achieved by antigen and a single injection of an anti-CD45 monoclonal antibody in rats.
Jäger MD; Tsui T; Aselmann H; Dahlke MH; Deiwick A; Neipp M; Klempnauer J; Wonigeit K; Schlitt HJ
Transplant Proc; 2001; 33(1-2):142. PubMed ID: 11266748
[No Abstract] [Full Text] [Related]
17. Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation.
Dengler TJ; Szabo G; Amann K; Nottmeyer W; Vahl C; Hagl S; Zimmermann R
Transplant Proc; 1998 May; 30(3):868-70. PubMed ID: 9595130
[No Abstract] [Full Text] [Related]
18. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
19. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
[No Abstract] [Full Text] [Related]
20. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.
Kamburova EG; Koenen HJ; van den Hoogen MW; Baas MC; Joosten I; Hilbrands LB
PLoS One; 2014; 9(11):e112658. PubMed ID: 25393622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
